Konsume
Interval Day Week Month
Newswire Search Past 90 Days 25 stories 8 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View

Related Topics
Topic # Mentions Topic Reach
collaboration4-
the3-
Prominent Journalists
Byline Articles Written Avg Reach
by PR Newswire 6 -
InSilico MedicineJun 22 2026Reviewed 1 -
By Salong Debbarma 1 -
InSilico MedicineJul 2 2026Reviewed 1 -
InSilico MedicineJul 3 2026Reviewed 1 -
InSilico MedicineJul 11 2026Reviewed 1 -
InSilico MedicineSep 2 2026Reviewed 1 -
Alina Maria Stan 1 -
Insilico MedicineSep 7 2026Reviewed 1 -
Staff Writer 1 -
InSilico MedicineJul 29 2026Reviewed 1 -
Kelsey Warner 1 -
by PR Newswire 1 -
InSilico MedicineJul 30 2026Reviewed 1 -
Rob Thubron 1 -
InSilico MedicineAug 4 2026Reviewed 1 -
InSilico MedicineSep 10 2026Reviewed 1 -
InSilico MedicineJun 17 2026 1 -
RTTNews Staff Writer 1 -
Gayathry Prakash 1 -


Generative AI-driven drug Rentosertib enters Phase III trial for idiopathic pulmonary fibrosis

InSilico MedicineSep 10 2026Reviewednews-medical.net


An AI-developed drug appeared to make patients biologically younger in a clinical trial

Rob Thubrontechspot.com


AI-designed drug candidate reverses biological age in clinical study

Insilico MedicineSep 7 2026Reviewednews-medical.net


Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial

Alina Maria Stanthenextweb.com


Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain

by PR Newswirethailand-business-news.com


Insilico Medicine releases frontier AI models for drug discovery

InSilico MedicineSep 2 2026Reviewednews-medical.net


Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer

InSilico MedicineAug 4 2026Reviewednews-medical.net


Insilico unveils standardized evaluation framework to validate AI-driven drug discovery models

InSilico MedicineJul 30 2026Reviewednews-medical.net


FDA grants fast track designation to Insilico's AI-designed mesothelioma drug candidate

InSilico MedicineJul 29 2026Reviewednews-medical.net


Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma

by PR Newswirethailand-business-news.com

Execution: 1.20 Seconds. 61.1 mb used.